# A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan

> **NCT03485144** · PHASE2 · COMPLETED · sponsor: **Medigen Vaccine Biologics Corp.** · enrollment: 54 (actual)

## Conditions studied

- Dengue

## Interventions

- **BIOLOGICAL:** TV003
- **BIOLOGICAL:** Placebo for TV003

## Key facts

- **NCT ID:** NCT03485144
- **Lead sponsor:** Medigen Vaccine Biologics Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-12
- **Primary completion:** 2019-05-10
- **Final completion:** 2019-05-10
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2019-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03485144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03485144, "A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03485144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*